Ivana Magovčević-Liebisch
Draig has appointed Ivana Magovčević-Liebisch as CEO
Read MoreBimekizumab offers fresh option for patients with chronic conditions
Read MorehVIVO celebrates landmark deal highlighting its role in advancing influenza therapy
Read MoreCollaboration aims to streamline manufacturing linking nhs early-phase expertise
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
